41.490
41.49 (0%)
As of Dec 20, 2024
Protagonist Therapeutics Inc [PTGX]
Source:
Company Overview
Protagonist Therapeutics, Inc are a biopharmaceutical company with peptide-based new chemical entities rusfertide and JNJ-2113 in different stages of development, all derived from our proprietary discovery technology platform.
| Country | United States |
| Headquarters | newark, california |
| Phone Number | (510) 474-0170 |
| Industry | manufacturing |
| CEO | Dinesh V. Patel, Ph.D. |
| Website | www.protagonist-inc.com |